O/m items only: glassware/lab supp/chem/biological materials & science equipment

The Office of Logistics and Acquisition Operations established a Blanket Purchase Agreement with Fisher Scientific Company L.L.C. on March 1, 2021, with an ultimate completion date of January 31, 2027, for laboratory supplies, glassware, chemicals, biological materials, and science equipment on an operations and maintenance basis.

Fisher Scientific, a for-profit limited liability company and wholly owned subsidiary of Thermo Electron Corporation, operates primarily under NAICS 424210 (Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers) and PSC 6640 (Laboratory Equipment and Supplies). The company supplies laboratory equipment, scientific products, chemicals, and biological materials to federal agencies without set-aside designations.

Work is performed in Pittsburgh, Pennsylvania. Performance extends nationwide across federal research and health agencies, with administrative oversight at the Office of Logistics and Acquisition Operations.

Recent BPA-call activity reflects sustained ordering across multiple National Institutes of Health institutes and centers. Notable calls include a $16,455.08 order from the National Institute of Neurological Disorders and Stroke on July 6, 2026, for a CryoPlus 2 Storage System; a $18,769 call from the National Heart, Lung, and Blood Institute on December 22, 2025, for biosafety cabinets; a $14,860.25 order from the National Institute of Diabetes and Digestive and Kidney Diseases on September 11, 2025, for a centrifuge; and a $24,999 call from the National Institute of Environmental Health Sciences on July 11, 2025, for an Applied Biosystems QuantStudio 3 Real-Time PCR System with laptop and training. Call values range from approximately ten thousand dollars to twenty-five thousand dollars, with orders spanning laboratory freezers, incubators, microscopy systems, sequencing kits, reagents, antibodies, and consumable supplies. Recent activity demonstrates consistent quarterly ordering across civilian federal research agencies supporting biomedical research infrastructure.